Information Provided By: 
Fly News Breaks for October 25, 2019
ATRA
Oct 25, 2019 | 14:12 EDT
Mizuho analyst Salim Syed noted that a report from Endpoints News has brought to light the apparent departure of Atara Biotherapeutics' Chief Scientific Officer Chris Haqq, who joined Elicio. Haqq is now listed on Elicio's website, and has been removed from Atara's site, but the company has not issued a press release or 8-K related to the matter, said Syed, who has inquired with the company to get more information. Syed has a Buy rating on Atara shares.
News For ATRA From the Last 2 Days
There are no results for your query ATRA
